Faculty Opinions recommendation of Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020309.793478810 ◽

2013 ◽

Author(s):

Arthur Kim

Keyword(s):

Direct Acting Antivirals ◽

Download Full-text

High virological cure rate and low rate of reinfection in a project to eradicate HCV in people who inject drugs at risk for non-adherence to direct-acting antivirals in Vienna

10.1055/s-0038-1654606 ◽

2018 ◽

Author(s):

A Schütz ◽

C Schwanke ◽

E Gutic ◽

T Lang ◽

R Schubert ◽

...

Keyword(s):

At Risk ◽

People Who Inject Drugs ◽

Direct Acting Antivirals ◽

Cure Rate ◽

Direct Acting ◽

Download Full-text

Treatment outcomes for hepatitis C genotype 1 infection with direct acting antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)

10.26226/morressier.572768e5d462b8029237f545 ◽

2016 ◽

Author(s):

Stefan Mauss

Keyword(s):

Hepatitis C ◽

Treatment Outcomes ◽

Direct Acting Antivirals ◽

Download Full-text

Faculty Opinions recommendation of Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.716298015.791652971 ◽

2012 ◽

Author(s):

Varun Garg

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Direct Acting Antivirals ◽

Download Full-text

Faculty Opinions recommendation of Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969197.793470534 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Direct Acting Antivirals ◽

Virus Genotype ◽

Genotype 1B ◽

Download Full-text

Faculty Opinions recommendation of Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718230957.793490174 ◽

2014 ◽

Author(s):

Christopher Cimarusti

Keyword(s):

Developing Countries ◽

Hepatitis C ◽

Large Scale ◽

Direct Acting Antivirals ◽

Treatment Access ◽

Direct Acting ◽

Minimum Costs ◽

Access Programs

Download Full-text

Faculty Opinions recommendation of Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726468907.793521728 ◽

2016 ◽

Author(s):

Doug Dieterich ◽

Dost Sarpel

Keyword(s):

Hepatocellular Carcinoma ◽

Direct Acting Antivirals ◽

Direct Acting ◽

Early Occurrence

Download Full-text

Faculty Opinions recommendation of Impact of All-Oral Direct-Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic Hepatitis C in the United States.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734161454.793557418 ◽

2019 ◽

Author(s):

Doug Dieterich ◽

Clara Rodriguez Rivas

Keyword(s):

United States ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

The United States ◽

Economic Outcomes ◽

Direct Acting Antivirals ◽

Download Full-text

All Oral Interferon-free Direct-acting Antivirals as Combination Therapies to Cure Hepatitis C

Current Molecular Medicine ◽

10.2174/1566524019666190104110439 ◽

2019 ◽

Vol 18 (7) ◽

pp. 409-435 ◽

Author(s):

Imran Shahid ◽

Munjed M. Ibrahim

Keyword(s):

Hepatitis C ◽

Combination Therapies ◽

Direct Acting Antivirals ◽

Download Full-text

Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study

Current Drug Safety ◽

10.2174/1574886313666180716111529 ◽

2018 ◽

Vol 13 (3) ◽

pp. 187-195 ◽

Author(s):

Eman I. Ahmed ◽

Wafaa Y. Abdel Wahed ◽

Essam A. Hassan ◽

Tarek I. Ahmed

Keyword(s):

Drug Effects ◽

Hcv Infection ◽

Adverse Drug Effects ◽

Direct Acting Antivirals ◽

Chronic Hcv Infection ◽

Chronic Hcv ◽

Direct Acting ◽

Fayoum Governorate

Download Full-text

Validation of a point-of-care rapid diagnostic test for hepatitis C for use in resource-limited settings

International Health ◽

10.1093/inthealth/ihy101 ◽

2019 ◽

Vol 11 (4) ◽

pp. 314-315

Author(s):

James S Leathers ◽

Maria Belen Pisano ◽

Viviana Re ◽

Gertine van Oord ◽

Amir Sultan ◽

...

Keyword(s):

Point Of Care ◽

Low Cost ◽

Rapid Diagnosis ◽

Direct Acting Antivirals ◽

Resource Limited Settings ◽

Rapid Diagnosis Test ◽

Resource Limited ◽

Specificity And Sensitivity ◽

Hcv Screening ◽

Abstract Background Treatment of HCV with direct-acting antivirals has enabled the discussion of HCV eradication worldwide. Envisioning this aim requires implementation of mass screening in resource-limited areas, usually constrained by testing costs. Methods We validated a low-cost, rapid diagnosis test (RDT) for HCV in three different continents in 141 individuals. Results The HCV RDT showed 100% specificity and sensitivity across different samples regardless of genotype or viral load (in samples with such information, 90%). Conclusions The HCV test validated in this study can allow for HCV screening in areas of need when properly used.

Download Full-text